This supports the results of a recent meta-analysis of data from 692 NSCLC patients which found that high YB-1 protein expression significantly correlated with poorer overall survival and clinicopathological features (Jiang et al., 2017). This evidence concerns the gene YBX1 and non-small cell lung carcinoma.